NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Regenerative Patch Technologies

Regenerative Patch Technologies

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://regenerativepatch.com/

Last Round

Grant

Jul 27, 2023

Total Funding Raised

$28.71M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Regenerative Patch Technologies is a biotechnology company that develops stem cell-based implant technology for the treatment of retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicineretinal implantage-related macular degenerationAMDgeographic atrophystem cell therapybioengineered implantbiotech startupophthalmologyclinical-stage biotechcell-based therapyeye surgeryvision restorationmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regenerative Patch Technologies Comps

Public and private peers based on sector, stage, and business model.

Regenerative Patch Technologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Regenerative Patch Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 27, 2023
StrategicApr 7, 2017
GrantMar 13, 2014

Regenerative Patch Technologies Investors

Notable investors and investment history

Regenerative Patch Technologies investors
InvestorRounds
The Marcus FoundationGrant
California Institute for Regenerative MedicineGrant
University of Southern CaliforniaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 57% MoM.

Regenerative Patch Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Regenerative Patch Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Regenerative Patch Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Employee Range9
Year Founded2012
Last FundingJul 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.